The global bioengineered protein drugs market is witnessing significant expansion, driven by the increasing prevalence of chronic diseases and rapid advancements in biopharmaceutical technologies. Valued at US$ 347.1 billion in 2023, the market is projected to reach US$ 672.7 billion by 2034, growing at a steady CAGR of 6.2% from 2024 to 2034. This growth reflects the rising importance of...